Next Article in Journal
Association of Oral Health Literacy and Dental Visitation in an Inner-City Emergency Department Population
Next Article in Special Issue
Effect of β-Glucan and Black Tea in a Functional Bread on Short Chain Fatty Acid Production by the Gut Microbiota in a Gut Digestion/Fermentation Model
Previous Article in Journal
SpainUDP: The Spanish Undiagnosed Rare Diseases Program
Previous Article in Special Issue
Rebuilding the Gut Microbiota Ecosystem
Open AccessReview

Breast Cancer and Its Relationship with the Microbiota

1
Department of Radiology, School of Medicine, and Biomedical Research Center, University of Granada, 18071 Granada, Spain
2
Health Research Institute of Granada (ibs.GRANADA), 18010 Granada, Spain
3
Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain
4
Department of Biochemistry and Molecular Biology II, School of Pharmacy, University of Granada, 18071 Granada, Spain
5
Institute of Nutrition and Food Technology “José Mataix”, Biomedical Research Center, Parque Tecnológico Ciencias de la Salud, University of Granada, Armilla, 18100 Granada, Spain
*
Authors to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2018, 15(8), 1747; https://doi.org/10.3390/ijerph15081747
Received: 6 July 2018 / Revised: 8 August 2018 / Accepted: 11 August 2018 / Published: 14 August 2018
(This article belongs to the Special Issue Gut Microbiome and Health)
The microorganisms that live symbiotically in human beings are increasingly recognized as important players in health and disease. The largest collection of these microorganisms is found in the gastrointestinal tract. Microbial composition reflects both genetic and lifestyle variables of the host. This microbiota is in a dynamic balance with the host, exerting local and distant effects. Microbial perturbation (dysbiosis) could contribute to the risk of developing health problems. Various bacterial genes capable of producing estrogen-metabolizing enzymes have been identified. Accordingly, gut microbiota is capable of modulating estrogen serum levels. Conversely, estrogen-like compounds may promote the proliferation of certain species of bacteria. Therefore, a crosstalk between microbiota and both endogenous hormones and estrogen-like compounds might synergize to provide protection from disease but also to increase the risk of developing hormone-related diseases. Recent research suggests that the microbiota of women with breast cancer differs from that of healthy women, indicating that certain bacteria may be associated with cancer development and with different responses to therapy. In this review, we discuss recent knowledge about the microbiome and breast cancer, identifying specific characteristics of the human microbiome that may serve to develop novel approaches for risk assessment, prevention and treatment for this disease. View Full-Text
Keywords: breast cancer; estrobolome; estrogens; microbiota breast cancer; estrobolome; estrogens; microbiota
MDPI and ACS Style

Fernández, M.F.; Reina-Pérez, I.; Astorga, J.M.; Rodríguez-Carrillo, A.; Plaza-Díaz, J.; Fontana, L. Breast Cancer and Its Relationship with the Microbiota. Int. J. Environ. Res. Public Health 2018, 15, 1747.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop